Pablo J Cagnoni insider trades

Open-market stock purchases and sales by Pablo J Cagnoni, President, Global Head of R&D at Incyte Corp, from SEC Form 4 filings since Mar 11, 2013.

Recent trades

DateStockTradeValue
Sep 15, 2026INCY Incyte CorpSold$1.1M
Sep 15, 2026INCY Incyte CorpSold$1.7M
Sep 15, 2026INCY Incyte CorpBought (not open market)—
Sep 15, 2026INCY Incyte CorpBought (not open market)—
Sep 15, 2026INCY Incyte CorpBought (not open market)—
Sep 15, 2026INCY Incyte CorpBought (not open market)—
Aug 19, 2026INCY Incyte CorpSold$1.4M
Aug 12, 2026INCY Incyte CorpSold$1.3M
Aug 5, 2026INCY Incyte CorpSold$1.3M
Jul 31, 2026INCY Incyte CorpSold$1.9M
Jul 16, 2026INCY Incyte CorpBought (not open market)—
Jul 16, 2026INCY Incyte CorpBought (not open market)—
Jul 16, 2026INCY Incyte CorpBought (not open market)—
Jul 15, 2026INCY Incyte CorpSold (not open market)$570K
Jul 14, 2026INCY Incyte CorpSold (not open market)$2.1M
Jun 1, 2026INCY Incyte CorpSold (not open market)$2.4M
May 6, 2026INCY Incyte CorpBought (not open market)—
Apr 17, 2026INCY Incyte CorpSold$1.8M
Apr 17, 2026INCY Incyte CorpBought (not open market)—
Apr 17, 2026INCY Incyte CorpBought (not open market)—
Apr 15, 2026INCY Incyte CorpBought (not open market)—
Mar 17, 2026INCY Incyte CorpSold$1.8M
Mar 17, 2026INCY Incyte CorpBought (not open market)—
Mar 17, 2026INCY Incyte CorpBought (not open market)—
Feb 19, 2026INCY Incyte CorpSold$1.9M

Companies traded

  • INCY Incyte Corp: 9 sales, last Sep 15, 2026
  • FUSN Fusion Pharmaceuticals Inc: other filings, last Jun 4, 2024
  • RUBY Rubius Therapeutics, Inc: 1 buy, 3 sales, last Feb 1, 2023
  • CRSP CRISPR Therapeutics AG: 5 sales, last Nov 19, 2019
  • ONXX Onyx Pharmaceuticals Inc: other filings, last Oct 1, 2013

Get free alerts when Pablo J Cagnoni files a new trade →